Prosecution Insights
Last updated: October 04, 2026

Mchale & Slavin, P.A.

Technology areas: Biotechnology & Pharmaceuticals • Transportation, E-Commerce & Mechanical Systems • Medical Devices & Mechanical Engineering

37 pending office actions • 30 clients • 37 examiners • 25 art units • 0 of 37 (0%) have an AI response strategy ready

Analysis

MCHALE & SLAVIN, P.A. has a significant presence in Biotechnology & Pharmaceuticals with 10608 career applications. The firm achieves a resolved allowance rate of 87.22 percent, maintaining this success over a very large volume of filings. Prosecution typically involves 2.94 average office actions per allowance, showing a consistent pace of resolution for their clients.

There are currently 30 pending office actions, indicating ongoing prosecution activity across their portfolio. The 2.94 average office actions per allowance suggests that most cases are resolved in under three actions, which is a notable efficiency given the 10608 career applications processed. This data provides a clear picture of the firm's high-volume experience and steady allowance outcomes in the biotech sector.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=10623 apps, methodology: how we score firms)

87.2%
Allowance Rate
n=10623
+0.55σ
Allowance Rate (norm)
n=10623
2.9
OAs to Allowance
n=7311
-0.31σ
OAs to Allow (norm)
n=7311
944 days
Time to Allowance
n=7311
+9.0pp
Interview Lift
n=10623
20.0%
RCE Rate
n=10623
2.4%
Appeal Rate
n=10623

Rejection Performance (% of received rejections ultimately overcome)

81.7%
§101 Overcome
n=644
82.6%
§102 Overcome
n=2962
83.1%
§103 Overcome
n=4619
84.5%
§112 Overcome
n=3314

Specialization & Scale

F01D, F05D, H10D
Top CPC Subclasses
12%
Top-3 CPC Share
n=10623
8
Practitioners
n=10623
1327.9
Apps / Practitioner
n=10623

Portfolio Summary

37
Total Pending OAs
22
Non-Final OAs
14
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 9 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

4
Overdue
1
Due this week
4
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 9 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (4)Due ≤ 7 days (1)Due ≤ 30 days (4)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

22
Hard (59%)
10
Medium (27%)
5
Easy (14%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other6 (16%)
§103 only9 (24%)
§102 only1 (3%)
§112 only4 (11%)
Double-patenting only1 (3%)
Multi-statute (no §101)16 (43%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

11
Life Sciences
30% of docket
0
Information Tech
0% of docket
1
Communications
3% of docket
0
Semiconductors
0% of docket
16
Mechanical / Eng
43% of docket
9
Business / Other
24% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

370 h
Manual time on pending OAs
74 h
Time saved (low, 20%)
130 h
Time saved (mid, 35%)
3.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
FREEMAN, JOSHUA E 1 82.0% +12.1%
GILES, EBONI N 1 63.3% +8.3%
CARTER, TARA ROSE E 1 80.7% +9.7%
PRESSLEY, PAUL DEREK 1 60.5% +28.1%
FENSTERMACHER, JASON B 1 46.9% +38.0%
LYNCH, CARLY W 1 51.8% +48.1%
KAMIKAWA, TRACY L 1 58.4% +37.3%
GANGLE, BRIAN J 1 76.7% +14.7%
WALSH, MICHAEL THOMAS 1 77.6% +26.5%
KINCAID, LESTER G 1 61.8% +7.7%

Hard Cases (22)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18699925 Mountable device for autonomous blood vessel interfacing and instrument actuation OKONAK, ELIZABETH LOUISE 8d
18413456 COMPOSITIONS AND METHODS FOR TREATING FLATWORMS NGUYEN, JOHN P 14d
18029149 Method for classifying a polysomnography recording into defined sleep stages BERHANU, ETSUB D 16d
18739458 SYSTEMS AND METHODS FOR MEDIA PLANNING USING ARTIFICIAL INTELLIGENCE PATEL, DIPEN M 29d
19557491 SUB-SONIC BULLET CASING FREEMAN, JOSHUA E —
19410786 DOOR LOCK WITH REMOTE VEIN READER GILES, EBONI N —
19375974 SPINAL IMPLANT HAVING COMPLIANT SURFACE CARTER, TARA ROSE E —
19039617 LOCKING MECHANISM FOR JOINING BONES AND RELATED METHOD KAMIKAWA, TRACY L —

Interview Candidates (7)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.

App #TitleExaminerDue in
19220053 SYSTEM AND METHOD FOR PLANT AGRICULTURE LYNCH, CARLY W 15d overdue
19350725 APPARATUS FOR DESTROYING ELECTRONIC DATA AND PROVIDING SELECTIVE STORAGE PRESSLEY, PAUL DEREK 3d overdue
19557491 SUB-SONIC BULLET CASING FREEMAN, JOSHUA E —
19267356 Method of minting an NFT from a timed transactional QR code generator for a payment receipt FENSTERMACHER, JASON B —
19039617 LOCKING MECHANISM FOR JOINING BONES AND RELATED METHOD KAMIKAWA, TRACY L —
18999335 Proteins and nucleic acids useful in vaccines targeting Klebsiella pneumoniae GANGLE, BRIAN J —
18964473 MULTI-STREAM TRASH RECEPTACLE WITH CONFIGURABLE DOLLY PLATFORM WALSH, MICHAEL THOMAS —

Client Portfolio (30 clients)

Top Art Units

Art UnitApps
37733
16742
36411
26221
37251
36431
37751
36131
16111
37991

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19557491 SUB-SONIC BULLET CASING Hornady Manufacturing Company FREEMAN, JOSHUA E 3641 §102§103 Non-Final OA — Pending Mar 05, 2026
19410786 DOOR LOCK WITH REMOTE VEIN READER Maxsafes Security, LLC GILES, EBONI N 2622 §103§112Other Non-Final OA — Pending Dec 05, 2025
19375974 SPINAL IMPLANT HAVING COMPLIANT SURFACE Integrity Intellect Inc. CARTER, TARA ROSE E 3773 §102§103§112 Non-Final OA — Pending Oct 31, 2025
19350725 APPARATUS FOR DESTROYING ELECTRONIC DATA AND PROVIDING SELECTIVE STORAGE Phiston Technologies, Inc. PRESSLEY, PAUL DEREK 3725 §103 Non-Final OA 3d overdue Pending Oct 06, 2025
19267356 Method of minting an NFT from a timed transactional QR code generator for a payment receipt Hd Networks, LLC FENSTERMACHER, JASON B §103 Non-Final OA — Pending Jul 11, 2025
19220053 SYSTEM AND METHOD FOR PLANT AGRICULTURE Jardin Holdings I, LLC LYNCH, CARLY W 3643 §103 Final Rejection 15d overdue Pending May 27, 2025
19039617 LOCKING MECHANISM FOR JOINING BONES AND RELATED METHOD Marc J. Levine KAMIKAWA, TRACY L 3775 §102§103§112 Non-Final OA — Pending Jan 28, 2025
18999335 Proteins and nucleic acids useful in vaccines targeting Klebsiella pneumoniae Evaxion Biotech A/S GANGLE, BRIAN J §112 Non-Final OA — Pending Dec 23, 2024
18964473 MULTI-STREAM TRASH RECEPTACLE WITH CONFIGURABLE DOLLY PLATFORM Suncast Technologies, LLC WALSH, MICHAEL THOMAS 3613 §102§103§112 Non-Final OA — Pending Dec 01, 2024
17772767 MOBILE SERVICE ACCESS METHOD AND DEVICE, SYSTEM, STORAGE MEDIUM, AND ELECTRONIC DEVICE Tony Cheung KINCAID, LESTER G §101§103§112 Non-Final OA — Pending Oct 30, 2024
18893412 Windshield washer cowling Wiperfill Holdings, LLC CONDO, VERONICA MARIE §112Other Non-Final OA — Pending Sep 23, 2024
18891379 Integrated precipitation and membrane filtration processes for isolation of potato proteins Lihme Protein Solutions Aps MERRIAM, ANDREW E §102§103§112 Non-Final OA — Pending Sep 20, 2024
18885975 RAPID EMERGENCY TOAD POISONING KIT AND METHODS OF USE THEREOF Toad Busters, LLC RHEE, KELSEY §101§102§103§112Other Non-Final OA — Pending Sep 16, 2024
18836398 Compositions and kits for use in wound healing, tissue regeneration and/or bone regeneration UNIVERSITÄTSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITÄT MAINZ BAEK, BONG-SOOK 1611 §102§103§112 Non-Final OA — Pending Aug 07, 2024
18771483 HAIR EXTENSION New Image Labs Corporation NOBREGA, TATIANA L 3799 §101§103 Final Rejection — Pending Jul 12, 2024
18727664 ANTI-KNOCK LOCK Xiamen Make Security Technology Co., Ltd. IGNACZEWSKI, JAMES EDWARD 3675 §102§103 Non-Final OA — Pending Jul 09, 2024
18750555 FORCED AIR CAMERA/CONTROL MODULE FOR BEAD BLAST CABINET Get Blacked Out, LLC NEIBAUR, ROBERT F §103§112 Non-Final OA — Pending Jun 21, 2024
18742374 PLIF SPACER Atlas Spine, Inc. MATTHEWS, TESSA M 3773 §102 Final Rejection — Pending Jun 13, 2024
18739458 SYSTEMS AND METHODS FOR MEDIA PLANNING USING ARTIFICIAL INTELLIGENCE Gale Force Digital Technologies, Inc. PATEL, DIPEN M 3621 §101§102 Final Rejection 29d Pending Jun 11, 2024
18735139 FLUORESCENT COLORED LIGHT EMITTING DIODE AND CONTROL SYSTEM FOR CREATING A LIGHT DISPLAY Fully Electronics Co., Ltd. STEVENSON, ANDRE C §102§103§112 Non-Final OA — Pending Jun 05, 2024
18732821 Proteins and nucleic acids useful in vaccines targeting Pseudomonas aeruginosa Evaxion Biotech A/S ZEMAN, ROBERT A 1645 §102§103§112 Non-Final OA — Pending Jun 04, 2024
18634385 Floor plank modification system Newgen Enterprises, LLC YE, XINWEN 1754 §103 Final Rejection — Pending Apr 12, 2024
18699925 Mountable device for autonomous blood vessel interfacing and instrument actuation Neurescue Aps OKONAK, ELIZABETH LOUISE 3792 §101§103 Final Rejection 8d Pending Apr 10, 2024
18698906 Method for survival prediction and for diagnosis and treatment of Type 2 Diabetes mellitus Nordisk Hjertecenter Aps HYUN, PAUL SANG HWA §101§102§103§112 Non-Final OA — Pending Apr 05, 2024
18413456 COMPOSITIONS AND METHODS FOR TREATING FLATWORMS New Guinea Flatworm Spray, Inc. NGUYEN, JOHN P 1619 §103§112 Final Rejection 14d Pending Jan 16, 2024
18556171 Antiviral compositions comprising liposome-encapsulated ascorbyl glucoside and natural extracts BIONEXT LABS LTD RONEY, CELESTE A 1612 §112 Non-Final OA — Pending Oct 19, 2023
18368839 STORAGE SHED Suncast Technologies, LLC BARLOW, ADAM G 3633 §103 Final Rejection — Pending Sep 15, 2023
18342847 BEVERAGE SERVICE STATION AND BAR Suncast Technologies, LLC WILKENS, JANET MARIE 3637 §103§112 Final Rejection — Pending Jun 28, 2023
18326336 Expandable and contractible garden hose Telebrands Corp. ZOLLINGER, NATHAN C 3746 §103Other Final Rejection — Pending May 31, 2023
18254456 A method and a system for filtering a suspension Chreto Aps BULLOCK, IN SUK C 1772 §103 Final Rejection — Pending May 25, 2023
18251818 Microfluidic flow cell and system for analyzing or diagnosing biofilms and cell cultures, and the use thereof Johannes Gutenberg-Universität Mainz KWAK, DEAN P 1798 §103 Final Rejection 5d Pending May 04, 2023
18029149 Method for classifying a polysomnography recording into defined sleep stages UNIVERSITÄTSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITÄT MAINZ BERHANU, ETSUB D 3791 §103§112Other Non-Final OA 16d Pending Mar 29, 2023
18028036 TRANSDERMAL INSULIN FORMULATIONS AND METHODS OF USE THEREOF Transdermal Delivery Solutions Corp. CHANDRA, GYAN 1674 §103 Non-Final OA 126d overdue Pending Mar 23, 2023
18177038 INTERVERTEBRAL DEVICES AND RELATED METHODS Expanding Innovations, Inc. PLIONIS, NICHOLAS J 3773 §103§112 Non-Final OA — Pending Mar 01, 2023
18002374 Kits and methods for the enrichment and detection of RNA viruses of the Coronaviridae family Johannes Gutenberg-Universität Mainz GILL, RACHEL B 1671 §103§112 Final Rejection — Pending Dec 19, 2022
17995601 Neoepitope immunotherapy with APC targeting unit Evaxion Biotech A/S DENT, ALANA HARRIS 1643 DP Final Rejection — Pending Oct 06, 2022
16970688 Novel IL-4-/IL-13-derived peptide compounds for the treatment or prevention of neurodegenerative or neuroinflammatory diseases UNIVERSITÄTSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITÄT MAINZ MCCOLLUM, ANDREA K 1674 §112 Non-Final OA 99d overdue Pending Aug 18, 2020

Managing Mchale & Slavin, P.A.'s Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month